BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 15090421)

  • 1. Intraocular and plasma levels of cellular fibronectin in patients with uveitis and diabetes mellitus.
    Probst K; Fijnheer R; Schellekens P; Rothova A
    Br J Ophthalmol; 2004 May; 88(5):667-72. PubMed ID: 15090421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunosuppressive acidic protein in intraocular fluids.
    Takeda Y; Yamaguchi K; Tamai M
    Jpn J Ophthalmol; 1994; 38(4):388-91. PubMed ID: 7723207
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of intravitreal bevacizumab on serum, aqueous, and vitreous humor levels of erythropoietin in patients with proliferative diabetic retinopathy.
    Cancarini A; Costagliola C; Dell'omo R; Romano M; Morescalchi F; Agnifili L; Ruggeri G; Semeraro F
    Minerva Endocrinol; 2014 Dec; 39(4):305-11. PubMed ID: 25371057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Profile of intraocular tumour necrosis factor-α and interleukin-6 in diabetic subjects with different degrees of diabetic retinopathy.
    Gustavsson C; Agardh CD; Agardh E
    Acta Ophthalmol; 2013 Aug; 91(5):445-52. PubMed ID: 22520269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophage migration inhibitory factor in ocular fluids of patients with uveitis.
    Taguchi C; Sugita S; Tagawa Y; Nishihira J; Mochizuki M
    Br J Ophthalmol; 2001 Nov; 85(11):1367-71. PubMed ID: 11673308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Vitreous and aqueous concentrations of proangiogenic, antiangiogenic factors and other cytokines in diabetic retinopathy patients with macular edema: Implications for structural differences in macular profiles.
    Patel JI; Tombran-Tink J; Hykin PG; Gregor ZJ; Cree IA
    Exp Eye Res; 2006 May; 82(5):798-806. PubMed ID: 16324700
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aqueous humor levels of cytokines are related to vitreous levels and progression of diabetic retinopathy in diabetic patients.
    Funatsu H; Yamashita H; Noma H; Mimura T; Nakamura S; Sakata K; Hori S
    Graefes Arch Clin Exp Ophthalmol; 2005 Jan; 243(1):3-8. PubMed ID: 15258777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aqueous humour levels of vascular endothelial growth factor and erythropoietin in patients with diabetic macular oedema before and after intravitreal erythropoietin injection.
    Lim JW; Han JR
    Clin Exp Ophthalmol; 2011 Aug; 39(6):537-44. PubMed ID: 21819507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aqueous humor and plasma vascular endothelial growth factor in uveitis-associated cystoid macular edema.
    Fine HF; Baffi J; Reed GF; Csaky KG; Nussenblatt RB
    Am J Ophthalmol; 2001 Nov; 132(5):794-6. PubMed ID: 11704050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of soluble CD14 and cytokine levels on diabetic macular edema and visual acuity.
    Umazume K; Usui Y; Wakabayashi Y; Okunuki Y; Kezuka T; Goto H
    Retina; 2013 May; 33(5):1020-5. PubMed ID: 23095769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aqueous levels of VEGF correlate with retinal non-perfusion areas in patients with diabetic macular edema and macular edema secondary to central retinal vein occlusion.
    Machalinska A; Mozolewska-Piotrowska K; Czepita M; Spoz W; Dzieciolowska M; Kubasik-Kladna K; Szmatloch K; Lubinski W; Safranow K; Pius-Sadowska E
    Klin Oczna; 2016 Sep; 117(4):225-229. PubMed ID: 29727107
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated immunoreactive-adrenomedullin levels in the aqueous humor of patients with uveitis and vitreoretinal disorders.
    Udono T; Takahashi K; Abe T; Shibahara S; Tamai M
    Peptides; 2002 Oct; 23(10):1865-8. PubMed ID: 12383875
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vitreous levels of somatostatin in patients with chronic uveitic macular oedema.
    Fonollosa A; Coronado E; Catalan R; Gutierrez M; Macia C; Zapata MA; Martinez-Alday N; Simo R; Garcia-Arumi J
    Eye (Lond); 2012 Oct; 26(10):1378-83. PubMed ID: 22878444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vitreous levels of erythropoietin in patients with macular oedema secondary to retinal vein occlusions: a comparative study with diabetic macular oedema.
    García-Arumí J; Fonollosa A; Macià C; Hernandez C; Martinez-Castillo V; Boixadera A; Zapata MA; Simo R
    Eye (Lond); 2009 May; 23(5):1066-71. PubMed ID: 18670462
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intravitreal VEGF levels in uveitis patients and treatment of uveitic macular oedema with intravitreal bevacizumab.
    Weiss K; Steinbrugger I; Weger M; Ardjomand N; Maier R; Wegscheider BJ; Wedrich A; El-Shabrawi Y
    Eye (Lond); 2009 Sep; 23(9):1812-8. PubMed ID: 19169227
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The correlation study of the expression of VEGF with t-PA and PAI expression in plasma and intraocular tissue in proliferative diabetic retinopathy].
    Wu S; He X
    Zhonghua Yan Ke Za Zhi; 2014 Jun; 50(6):448-53. PubMed ID: 25241978
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Interplay between elevated cellular fibronectin and plasma fibrin clot properties in type 2 diabetes.
    Konieczyńska M; Bryk AH; Malinowski KP; Draga K; Undas A
    Thromb Haemost; 2017 Aug; 117(9):1671-1678. PubMed ID: 28569923
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased levels of vascular endothelial growth factor and interleukin-6 in the aqueous humor of diabetics with macular edema.
    Funatsu H; Yamashita H; Noma H; Mimura T; Yamashita T; Hori S
    Am J Ophthalmol; 2002 Jan; 133(1):70-7. PubMed ID: 11755841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Changes in aqueous and vitreous inflammatory cytokine levels in diabetic macular oedema: a systematic review and meta-analysis.
    Minaker SA; Mason RH; Lahaie Luna G; Farahvash A; Garg A; Bhambra N; Bapat P; Muni RH
    Acta Ophthalmol; 2022 Feb; 100(1):e53-e70. PubMed ID: 33945678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum and intraocular concentrations of erythropoietin and vascular endothelial growth factor in patients with type 2 diabetes and proliferative retinopathy.
    Semeraro F; Cancarini A; Morescalchi F; Romano MR; dell'Omo R; Ruggeri G; Agnifili L; Costagliola C
    Diabetes Metab; 2014 Dec; 40(6):445-51. PubMed ID: 24878492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.